BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 27, 1998

View Archived Issues

Alteon: nine-month highlights

Read More

Allelix: 1998 year-end results

Read More

Aronex: Q3 1998 highlights

Read More

ImClone Systems: Q3 1998 highlights

Read More

Japanese researchers present positive findings in Synsorb Pk trial

Read More

Amarillo Biosciences initiates phase III clinical trial with oral interferon alfa

Read More

Onyx reports encouraging phase II results of ONYX-015 in head and neck cancer

Read More

Cell Genesys describes improved vectors for gene therapy

Read More

Targeted Genetics and Medeva form collaboration to develop CF treatment

Read More

Schering-Plough's p53 gene therapy continues to make impressive progress

Read More

Access plans for clinical development of AP-5070

Read More

New treatment option for pediatric HIV/AIDS now available in U.S.

Read More

NE reuptake inhibitor from Lilly shows antiobesity activity in animal models

Read More

Cerus makes steady progress with platelet pathogen inactivation system

Read More

Novel agents for HIV: protease inhibitor/reverse transcriptase inhibitor conjugates

Read More

Ferring patents dual T-cell proliferation and protein farnesyltransferase inhibitors

Read More

Olopatadine combination more effective than loratadine monotherapy in allergic conjunctivitis

Read More

Viral and nonviral serine protease inhibitors developed at Emory University

Read More

British Biotech expands pipeline of MMP inhibitors

Read More

Montelukast shows synergistic efficacy with antihistamines in allergic rhinitis

Read More

U.S. university researchers claim cocaine analogues for drug addiction, PD and depression

Read More

Continued positive results with fexofenadine in patients with CIU

Read More

Zileuton trials recommended for new indication: atopic dermatitis

Read More

Somatostatin sst2 agonists synthesized at Merck & Co.

Read More

SA-9499 identified as potent and selective LTA4 hydrolase inhibitor at Santen

Read More

New prodrugs of CPI derivatives designed by Kyorin and Sagami

Read More

PDE4 inhibitor developed at Celltech superior to available antiasthmatic agents in rabbit model

Read More

Immunex files sBLA for Enbrel as treatment for juvenile rheumatoid arthritis

Read More

More on the contraceptive effects, anti-HIV activity of WHI compounds

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 10, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing